Related Experiment Video
Updated: Jul 9, 2026

Electroconvulsive Seizures in Rats and Fractionation of Their Hippocampi to Examine Seizure-induced Changes in Postsynaptic Density Proteins
Published on: August 15, 2017
Electroconvulsive therapy and antibiotics: a case report
Irving M Reti1, Dimitry S Davydow
1Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine, Baltimore, MD 21205, USA. imreti@jhmi.edu
Abstract:
Infections are common comorbid conditions in hospitalized patients, including those receiving electroconvulsive therapy (ECT). In this report, we demonstrate the fluoroquinolone class of antibiotics can be associated with prolonged electroconvulsive seizure duration. We describe an 82-year-old woman treated with the fluoroquinolone, moxifloxacin, during a course of ECT. After previously tolerating ECT well, introduction of moxifloxacin for a respiratory tract infection was associated with prolonged seizure duration despite complete resolution of her respiratory complaint. Taken together with other evidence that fluoroquinolones lower seizure threshold, this report suggests fluoroquinolones should be avoided in patients receiving ECT.
Insights
Fluoroquinolone antibiotics, like moxifloxacin, may prolong electroconvulsive therapy (ECT) seizures. This class of drugs should be avoided in patients undergoing ECT to prevent extended seizure durations.
Area of Science:
- Neurology
- Pharmacology
- Infectious Diseases
Background:
- Infections are frequent in hospitalized patients, often requiring antibiotic treatment.
- Electroconvulsive therapy (ECT) is a medical procedure used for specific psychiatric conditions.
- Managing comorbidities during ECT requires careful consideration of potential drug interactions.
Observation:
- A case study involving an 82-year-old woman undergoing ECT is presented.
- The patient was treated with moxifloxacin, a fluoroquinolone antibiotic, for a respiratory infection.
- Previously, the patient tolerated ECT without complications.
Findings:
- Introduction of moxifloxacin was associated with a significant prolongation of electroconvulsive seizure duration.
- The prolonged seizure duration occurred despite the successful treatment of the patient's respiratory infection.
- This observation aligns with existing evidence suggesting fluoroquinolones can lower the seizure threshold.
Implications:
- Fluoroquinolone antibiotics may pose a risk for patients undergoing ECT due to their effect on seizure threshold.
- Clinicians should exercise caution and consider alternative antibiotics in patients receiving ECT.
- Further research is warranted to fully elucidate the interaction between fluoroquinolones and ECT.
Related Concept Videos
Electroconvulsive Therapy
Epilepsy and Seizures: Overview
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
Brain Abscess l: Introduction
Psychosis: Goals of Pharmacotherapy
Acute Pyelonephritis II: Diagnostic Studies and Management
Treating Helicobacter pylori in Peptic Ulcers: Antimicrobial Therapy
